Navigation Links
LCA-Vision to Present at the Noble Financial Eighth Annual Equity Conference
Date:1/12/2012

CINCINNATI, Jan. 12, 2012 /PRNewswire/ -- LCA-Vision Inc. (NASDAQ: LCAV), a leading provider of laser vision correction services under the LasikPlus® brand, today announced that management will present at the Noble Financial Eighth Annual Equity Conference on Tuesday, January 17, 2012, at 3:00 p.m. Eastern time.  A live and archived webcast of the presentation will be available at the Investor Relations section of LCA-Vision's website at www.lasikplus.com.
The conference is being held at the Hard Rock Hotel in Hollywood, Fla.

About LCA-Vision Inc./LasikPlus®
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, operates 53 LasikPlus® fixed-site laser vision correction centers in 26 states and 41 markets in the United States.  Additional company information is available at www.lca-vision.com and www.lasikplus.com.

Earning Trust Every Moment; Transforming Lives Every Day.For Additional InformationCompany Contact:Investor Relations Contact:Barb Kise

Jody CainLCA-Vision Inc.

LHA513-792-9292

310-691-7100


'/>"/>
SOURCE LCA-Vision Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. LCA-Vision Announces CEO Resignation
2. LCA-Vision Names Michael J. Celebrezze CFO
3. PharmAthene to Present at the Noble Financial Eighth Annual Equity Conference on Tuesday, January 17, 2012
4. Inovio Pharmaceuticals to Present at Noble Financial 8th Annual Equity Conference
5. NW Bio to Present Today at the OneMedForum SF 2012 Conference
6. Chembio Presenting at Biotech Conference
7. 3SBio Inc. to Present at the UBS Greater China Conference 2012
8. PAREXEL International to Present at J.P. Morgan Healthcare Conference
9. Reata Pharmaceuticals to Present at 30th Annual J.P. Morgan Healthcare Conference
10. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
11. InterMune to Present at J. P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 22, 2013   Oligomerix, Inc. , a ... modifying therapeutics for Alzheimer,s disease (AD) and related ... Series B financing, which includes both issuance of ... represent approximately $2.8M in new investments in the ... the raise. Funding from the ...
(Date:5/22/2013)... NEW ORLEANS , May 22, 2013 /PRNewswire/ ... regenerative medicine, presented new data generated in collaboration with ... leading health economics consultancy) demonstrating the significant healthcare resource ... venous leg ulcers (VLU) place upon the US healthcare ... which reveal annual costs of up to $15 billion ...
(Date:5/22/2013)... May 22, 2013 AudioNotch ... therapy for tinnitus treatment. AudioNotch is pleased to ... With clinic locations in both British Columbia and ... audiology and hearing services. AudioNotch's tinnitus treatment program ... Upon entering a Destination Hearing clinic, patients have ...
(Date:5/22/2013)... Alton Housing Authority was hit by bed ... that their presence has already caused the company $35,000 ... such big spending, My Cleaning Products shared a way ... said in the report that to clear the infestation ... that, its employees also attended a mandatory training on bed ...
Breaking Biology Technology:Oligomerix, Inc. Completes Series B Financing 2Oligomerix, Inc. Completes Series B Financing 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 4AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing 2Bed Bugs Cost Alton Housing Authority $35,000; New Help, How to Kill Bed Bugs With Less Expense, Introduced by My Cleaning Products 2
... ) today announced the Webcast of its fourth quarter and year-end 2008 ... on Tuesday, February 10, and will include remarks by Peer M. Schatz, ... What: Webcast of QIAGEN,s fourth quarter ... results call, When: ...
... Commence Tender Offer for All Shares of Common StockAt ... Feb. 3 PharmaNet Development Group, Inc. (the "Company" ... provider of clinical development services, today announced that it ... affiliates of JLL Partners, Inc. ("JLL"). Under the terms ...
... Therapeutic Approach Provides HIV-Resistant Immune CellsRICHMOND, Calif., Feb. 3 ... announced today that its collaborators at the University ... trial to evaluate SB-728-T for the treatment of HIV/AIDS. ... technology, SB-728-T has been shown in an animal ...
Cached Biology Technology:Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Fourth Quarter and Year-End 2008 Financial Results Call Set for February 10 2PharmaNet Development Group Agrees to be Acquired by JLL Partners 2PharmaNet Development Group Agrees to be Acquired by JLL Partners 3PharmaNet Development Group Agrees to be Acquired by JLL Partners 4PharmaNet Development Group Agrees to be Acquired by JLL Partners 5PharmaNet Development Group Agrees to be Acquired by JLL Partners 6PharmaNet Development Group Agrees to be Acquired by JLL Partners 7Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS 2Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS 3Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS 4Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS 5Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS 6Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS 7
(Date:5/22/2013)... feared Legionella pneumophila bacteria is responsible for ... In order to infect us, this pathogen has developed ... go unnoticed in our cells, thus avoiding these acting ... Basque biosciences research centre, CIC bioGUNE, in which teams ... USA and the National Supercomputation Centre in Barcelona (BSC) ...
(Date:5/22/2013)... May 22, 2013. Plastic additives known as phthalates ... everywhere: They turn up in flooring, plastic cups, ... the Centers for Disease Control and Preventionthe bodies ... have come under increasing scrutiny. A growing collection ... can leech from packaging and mix with food) ...
(Date:5/21/2013)... A new analysis shows that the nation,s land ... enough algae to produce up to 25 billion gallons ... one-twelfth of the country,s yearly needs. , The findings ... that would be needed to grow significant amounts of ... were published in the May 7 issue of ...
Breaking Biology News(10 mins):Mechanism discovered which aids Legionella to camouflage itself in the organism 2Study links chemicals widely found in plastics and processed food to elevated blood pressure in children and teens 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4
... burned your finger on a hot stove? Imagine what it's ... feet all the time and know there's virtually nothing you ... it's a common complication of many diseases and medical conditions, ... pain, which is caused by damage to sensory neurons that ...
... biochemists reveal the first structural details of a family ... present in a variety of bacteria. The discovery was ... is the first look at how microcompartments are built, ... Yeates, UCLA professor of chemistry and biochemistry, and a ...
... The recent discovery of citrus greening (huanglongbing) in samples ... threat to Florida's $9 billion commercial citrus industry. Proper ... amount of crop loss caused by this disease, say ... greening is a bacterial disease that affects the phloem ...
Cached Biology News:Scientists use gene transfer technology and common virus to block neuropathic pain 2Scientists use gene transfer technology and common virus to block neuropathic pain 3Scientists use gene transfer technology and common virus to block neuropathic pain 4Nighttime Dying Linked To Sleep Apnea From Brain Cell Loss 2Nighttime Dying Linked To Sleep Apnea From Brain Cell Loss 3
... DNA Ladder is suitable for ... to 16 kb by agarose ... can be visualized by ethidium ... be detected on Southern blots ...
...
... Hormone Receptor 2 ( Abpromise ... Antigen: Synthetic peptide: AFRHCNPNGTWDFMHSLN, ... of Human Parathyroid Hormone Receptor 2 ... 5746 Swiss ...
... 5 ml Dynabeads Mouse pan ... anti-B220 monoclonal antibody. For the efficient ... B cells directly from spleen or ... is expressed on mouse B cells ...
Biology Products: